Clinical Trials Directory

Trials / Unknown

UnknownNCT05084690

Mirror Illusion Training and Cross-education

Mirror Illusion Training to Improve Contralateral Arm Strength

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Texas Christian University · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Cross-education describes the transfer of motor performance to the opposite limb following unilateral training and is primarily explained by adaptations within the brain. The mirror training hypothesis suggests that illusionary mirror visual feedback may augment the cross-education of strength to the untrained, contralateral limb. The purpose of this project is to examine how the use of illusionary mirror visual feedback shapes the neuromuscular adaptations that occur for both limbs during unilateral (single-limb) strength training. Our hypothesis is that mirror training will augment the level of cross-education for the untrained arm.

Detailed description

Recent empirical evidence shows a heightened level of strength transfer with the use of illusionary mirror visual feedback, but this was shown for the small muscles of the wrist during isokinetic training. It is unknown if larger, multi-joint muscles respond favorably to mirror training in practical settings. A randomized controlled study design will allocate approximately 20 participants into two groups. One group will perform unilateral strength training with illusionary mirror visual feedback (Mirror) and the other will perform the same unilateral strength training but without a mirror (No-Mirror). The intervention will involve four weeks of unilateral strength training performed twice weekly at high intensities (\>80%1RM).

Conditions

Interventions

TypeNameDescription
OTHERUnilateral resistance trainingUnilateral resistance training of the elbow flexors
OTHERIllusionary mirror visual feedbackModified Ramachandran's mirror box

Timeline

Start date
2021-07-19
Primary completion
2023-08-19
Completion
2023-08-19
First posted
2021-10-20
Last updated
2021-10-20

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05084690. Inclusion in this directory is not an endorsement.